1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Epigenetic differences at immune and type 1 diabetes susceptibility genes in blood from young children after COVID-19 infection
- Contribution to journal › Article
- 2024
-
Mark
Vitamin D insufficiency in infants with increased risk of developing type 1 diabetes : A secondary analysis of the POInT Study
- Contribution to journal › Article
-
Mark
Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes
- Contribution to journal › Article
- 2023
-
Mark
SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood
- Contribution to journal › Article
- 2022
-
Mark
Elevations in blood glucose before and after the appearance of islet autoantibodies in children
- Contribution to journal › Article
-
Mark
Genetic regulation of RNA splicing in human pancreatic islets
- Contribution to journal › Article
- 2019
-
Mark
Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk : The GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol
- Contribution to journal › Article
-
Mark
Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials—GPPAD-02 study design and first results
- Contribution to journal › Article
- 2008
-
Mark
HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: Analysis of the Type 1 Diabetes Genetics Consortium families
- Contribution to journal › Article
